{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:50:53Z","timestamp":1773352253418,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12931-015-0295-2","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T07:27:09Z","timestamp":1447658829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care"],"prefix":"10.1186","volume":"16","author":[{"given":"Yogesh Suresh","family":"Punekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H","family":"Landis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keele","family":"Wurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoa","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"295_CR1","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015. http:\/\/www.goldcopd.org\/uploads\/users\/files\/GOLD_Report_2015_Feb18.pdf . Accessed 30 April 2015."},{"key":"295_CR2","unstructured":"Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update) NICE guidelines. 2010. http:\/\/www.nice.org.uk\/nicemedia\/live\/13029\/49397\/49397.pdf . Accessed 30 April 2015."},{"key":"295_CR3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.mcna.2012.05.002","volume":"96","author":"SR Rosenberg","year":"2012","unstructured":"Rosenberg SR, Kalhan R. An integrated approach to the medical treatment of chronic obstructive pulmonary disease. Med Clin North Am. 2012;96:811\u201326.","journal-title":"Med Clin North Am"},{"key":"295_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/pop.2008.0048","volume":"13","author":"GB Diette","year":"2010","unstructured":"Diette GB, Orr P, McCormack MC, Gandy W, Hamar B. Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines? Popul Health Manag. 2010;13:21\u20136.","journal-title":"Popul Health Manag"},{"key":"295_CR5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1185\/03007995.2011.583230","volume":"27","author":"K Fitch","year":"2011","unstructured":"Fitch K, Iwasaki K, Pyenson B, Plauschinat C, Zhang J. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Curr Med Res Opin. 2011;27:1425\u20139.","journal-title":"Curr Med Res Opin"},{"key":"295_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/COPD.S16396","volume":"6","author":"GD Salinas","year":"2011","unstructured":"Salinas GD, Williamson JC, Kalhan R, Thomashow B, Scheckermann JL, Walsh J, et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis. 2011;6:171\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"295_CR7","doi-asserted-by":"publisher","unstructured":"Jochmann A, Neubauer F, Miedinger D, Schafroth S, Tamm M, Leuppi JD. General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss medical weekly. 2010; doi: 10.4414\/smw.2010.13053 .","DOI":"10.4414\/smw.2010.13053"},{"key":"295_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.rmed.2011.09.010","volume":"106","author":"X Perez","year":"2012","unstructured":"Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. Barriers to adherence to COPD guidelines among primary care providers. Respir Med. 2012;106:374\u201381.","journal-title":"Respir Med"},{"key":"295_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4104\/pcrj.2010.00059","volume":"20","author":"MT Dransfield","year":"2011","unstructured":"Dransfield MT, Bailey W, Crater G, Emmett A, O'Dell DM, Yawn B. Disease severity and symptoms among patients receiving monotherapy for COPD. Prim Care Respir J. 2011;20:46\u201353.","journal-title":"Prim Care Respir J"},{"key":"295_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/COPD.S54417","volume":"9","author":"YS Punekar","year":"2014","unstructured":"Punekar YS, Shukla A, Mullerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65\u201373.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"295_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/15412555.2014.933953","volume":"12","author":"YS Punekar","year":"2015","unstructured":"Punekar YS, Wurst K, Shukla A. Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study. COPD. 2015;12(3):267\u201375.","journal-title":"COPD"},{"key":"295_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00151829-200605060-00012","volume":"5","author":"E Murtagh","year":"2006","unstructured":"Murtagh E, O'Neill C, McAllister D, Kee F, Macmahon J, Heaney LG. A Cross-Sectional Comparison of Direct Medical Care Costs among COPD and Asthma Patients Living in the Community in Northern Ireland. Treat Respir Med. 2006;5:495\u2013501.","journal-title":"Treat Respir Med"},{"key":"295_CR13","first-page":"98","volume":"7","author":"CM Blanchette","year":"2014","unstructured":"Blanchette CM, Gross NJ, Altman P. Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend. Am Health Drug Benefits. 2014;7:98\u2013106.","journal-title":"Am Health Drug Benefits"},{"key":"295_CR14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/resp.12453","volume":"20","author":"T Simon-Tuval","year":"2015","unstructured":"Simon-Tuval T, Maimon N. Tiotropium as part of inhaled polytherapy: Adherence and associated health-care utilization. Respirology. 2015;20:304\u201311.","journal-title":"Respirology"},{"key":"295_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.rmed.2010.07.007","volume":"105","author":"F Penning-van Beest","year":"2011","unstructured":"Penning-van Beest F, van Herk-Sukel M, Gale R, Lammers JW, Herings R. Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis. Respir Med. 2011;105:259\u201365.","journal-title":"Respir Med"},{"key":"295_CR16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105296","volume":"9","author":"KE Wurst","year":"2014","unstructured":"Wurst KE, Punekar YS, Shukla A. Treatment evolution after COPD diagnosis in the UK primary care. PLoS One. 2014;9, e105296.","journal-title":"PLoS One"},{"key":"295_CR17","unstructured":"Datalink. CPRD. http:\/\/www.cprd.com\/home\/ . Accessed 30 April 2015."},{"key":"295_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","volume":"11","author":"NF Khan","year":"2010","unstructured":"Khan NF, Perera R, Harper S, Rose PW. Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases. BMC Fam Pract. 2010;11:1.","journal-title":"BMC Fam Pract"},{"key":"295_CR19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/PPA.S40736","volume":"7","author":"CM Kozma","year":"2013","unstructured":"Kozma CM, Dickson M, Phillips AL, Meletiche DM. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. 2013;7:509\u201316.","journal-title":"Patient Prefer Adherence"},{"key":"295_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","volume":"50","author":"JF Steiner","year":"1997","unstructured":"Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105\u201316.","journal-title":"J Clin Epidemiol"},{"key":"295_CR21","unstructured":"Department of Health, UK. NHS reference costs 2013-14. Available at: https:\/\/www.gov.uk\/government\/collections\/nhs-reference-costs . Accessed on April 30, 2015."},{"key":"295_CR22","unstructured":"Buckingham RJ, Lowe D, Pursey NA, Roberts CM, Stone RA. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: clinical audit of COPD exacerbations admitted to acute NHS units across the UK: Royal College of Physicians, British Thoracic Society, British Lung Foundation. 2008. https:\/\/www.rcplondon.ac.uk\/sites\/default\/files\/report-of-the-national-copd-audit-2008-clinical-audit-of-copd-exacerbations-admitted-to-acute-nhs-units-across-the-uk.pdf . Accessed 30 April 2015."},{"key":"295_CR23","unstructured":"Personal Social Services Research Unit U. Unit Costs of Health and Social Care 2014. Available at: http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2014\/ . Accessed on September 14, 2015."},{"key":"295_CR24","unstructured":"Prescribing and Primary Care team, Health and Social Care Information Centre. Prescription Cost Analysis, England 2014. http:\/\/www.hscic.gov.uk\/searchcatalogue?productid=14494&q=title%3a%22Prescription+Cost+Analysis%2c+England%22+!quarterly&sort=Relevance&size=10&page=1#top . Accessed 30 April 2015."},{"issue":"2","key":"295_CR25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000368365","volume":"89","author":"F Braido","year":"2015","unstructured":"Braido F, Baiardini I, Scichilone N, Sorino C, Di Marco F, Corsico A, et al. Disability in moderate chronic obstructive pulmonary disease: prevalence, burden and assessment - results from a real-life study. Respiration. 2015;89(2):100\u20136.","journal-title":"Respiration"},{"key":"295_CR26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/COPD.S62750","volume":"9","author":"D Price","year":"2014","unstructured":"Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889\u2013904.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"295_CR27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.amjopharm.2010.10.002","volume":"8","author":"BC Stuart","year":"2010","unstructured":"Stuart BC, Simoni-Wastila L, Zuckerman IH, Davidoff A, Shaffer T, Yang HW, et al. Impact of maintenance therapy on hospitalization and expenditures for medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother. 2010;8(5):441\u201353.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"295_CR28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.rmed.2010.09.006","volume":"105","author":"EL Toy","year":"2011","unstructured":"Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, et al. Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105(3):435\u201341.","journal-title":"Respir Med"},{"issue":"3","key":"295_CR29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjopharm.2012.04.002","volume":"10","author":"L Simoni-Wastila","year":"2012","unstructured":"Simoni-Wastila L, Wei YJ, Qian J, Zuckerman IH, Stuart B, Shaffer T, et al. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a medicare population. Am J Geriatr Pharmacother. 2012;10(3):201\u201310.","journal-title":"Am J Geriatr Pharmacother"},{"key":"295_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1465-9921-9-62","volume":"9","author":"RC Jones","year":"2008","unstructured":"Jones RC, Dickson-Spillmann M, Mather MJ, Marks D, Shackell BS. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res. 2008;9:62.","journal-title":"Respir Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0295-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T19:44:19Z","timestamp":1498247059000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-015-0295-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1186\/s12931-015-0295-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]},"article-number":"141"}}